Macey Luo-Souza
Psychiatric/Mental Health, Child & Adolescent · Honolulu, HINPI 1891947669
Payments from drug & device makers
Across 433 payments — averaging $26.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Sunovion Pharmaceuticals Inc.$618
- plus $3K from 12 others
What the payments were for
- Food & beverage$11,485100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 74 | $2,556 |
| AbbVie | 61 | $1,773 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,297 |
| Alkermes, Inc. | 48 | $1,212 |
| Neurocrine Biosciences, Inc. | 27 | $1,141 |
| Sunovion Pharmaceuticals Inc. | 45 | $618 |
| Otsuka America Pharmaceutical, Inc. | 24 | $592 |
| Johnson & Johnson | 21 | $466 |
| Lundbeck LLC | 19 | $345 |
| E.r. Squibb & Sons, L.L.C. | 9 | $284 |
| Indivior Inc. | 11 | $276 |
| Vanda Pharmaceuticals Inc. | 13 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $232 |
| Axsome Therapeutics, Inc. | 5 | $204 |
| Sage Therapeutics, LLC | 1 | $110 |
| Idorsia Pharmaceuticals US Inc | 3 | $70 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few psychiatric/mental health, child & adolescent providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $329 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health, child & adolescent in Honolulu
- Katherine Gardner BougardHonolulu$531
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.